Lung Function and Sputum Characteristics of Patients with Severe Asthma During an Induced Exacerbation by Double-Blind Steroid Withdrawal
- 1 July 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (1) , 93-99
Abstract
Some patients with severe asthma are difficult to control and suffer from frequent exacerbations, whereas others remain stable with anti-inflammatory therapy. To investigate mechanisms of exacerbations, we compared 13 patients 20 to 51 yr of age (11 female, two male) with difficult-to-control asthma (two or more exacerbations during the previous year) and 15 patients 20 to 47 yr of age (13 female, two male) with severe but stable asthma (no exacerbations) after matching for sex, age, atopy, lung function, airway responsiveness, and medication. Exacerbations were induced by double-blind, controlled tapering of inhaled corticosteroids (fluticasone propionate) at weekly intervals. FEV1, airway responsiveness for methacholine (PC20MCh) and hypertonic saline (HYP slope), eosinophils and soluble markers (ECP, albumin, IL-6, IL-8) in induced sputum were assessed at baseline and during exacerbation (peak flow < 60% of personal best), or after 5 wk if no exacerbation occurred. Steroid tapering caused a decrease (mean ± SEM) in FEV1 (12.1 ± 3.1% pred; p = 0.045), PC20MCh (2.1 ± 0.4 doubling dose; p = 0.004) and HYP slope (1.7 ± 0.3 doubling dose; p = 0.001), and an increase in sputum eosinophils (10 ± 3%; p = 0.008) and soluble markers for the two groups combined, without significant differences between the groups. Patients with difficult-to-control asthma had more exacerbations than did the stable asthmatics during both steroid tapering (7 versus 2; p = 0.022) and corticosteroid treatment (6 versus 0; p = 0.003). Exacerbations during steroid treatment in the patients with difficult-to-control asthma were associated with a decrease in FEV1 and PC20MCh, but not in HYP slope or increase in sputum eosinophils. We conclude that tapering of inhaled corticosteroids induces a rapid, reversible flare-up of eosinophilic airway inflammation. Patients with difficult-to-control asthma may develop exacerbations despite treatment with inhaled corticosteroids, which appear to have an eosinophil-independent mechanism. This implies that assessment of the nature of exacerbations may contribute to improved treatment for these patients. in ‘tKeywords
This publication has 27 references indexed in Scilit:
- Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational studyBMJ, 1997
- Stabilization of Asthma MortalityAnnals of Allergy, Asthma & Immunology, 1997
- The costs of asthmaEuropean Respiratory Journal, 1996
- Prospective Study of Hospitalization for Asthma. A Preliminary Risk Factor ModelAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Patterns of Asthma Mortality in Philadelphia from 1969 to 1991New England Journal of Medicine, 1994
- Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.Thorax, 1993
- Asthma—United States, 1980-1990JAMA, 1992
- Markers of Risk of Asthma Death or Readmission in the 12 Months Following a Hospital Admission for AsthmaInternational Journal of Epidemiology, 1992
- A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroidClinical & Experimental Allergy, 1992
- A case-control study of deaths from asthma.Thorax, 1986